97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details
臨床試験数 : 2,527 / 薬物数 : 1,465 - (DrugBank : 259) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202
| No. | TrialID | Date_ enrollment  | Date_ registration  | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor  | Secondary_ sponsor  | Recruitment_ Status  | Inclusion_ agemin  | Inclusion_ agemax  | Inclusion_ gender  | Target_ size  | Phase | Countries | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03104036 (ClinicalTrials.gov)  | June 19, 2017 | 27/3/2017 | Faecal Bacteriotherapy for Ulcerative Colitis | Faecal Bacteriotherapy for Ulcerative Colitis | Ulcerative Colitis | Other: Faecal bacterial transplantation;Drug: Mesalazine 4G Enema | Institute for Clinical and Experimental Medicine | Institute of Animal Physiology and Genetics Academy of Science Czech Republic | Completed | 18 Years | 70 Years | All | 61 | Phase 2 | Czechia;Czech Republic | 
| 2 | NCT01757964 (ClinicalTrials.gov)  | December 2012 | 22/12/2012 | Bacteriotherapy in Pediatric Inflammatory Bowel Disease | Bacteriotherapy in Pediatric Inflammatory Bowel Disease | Inflammatory Bowel Disease;Crohn's Disease;Ulcerative Colitis;CD | Biological: Bacteriotherapy | David Suskind | Seattle Children's Hospital | Completed | 12 Years | 21 Years | All | 13 | Phase 1 | United States |